Clinical Trial Update: Drug Eluting Stent (DES) in Primary Angioplasty [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating a Drug Eluting Stent used in primary angioplasty for acute myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Drug-Eluting Stent (DES) (drug-eluting stent)

Snippet

Sponsor: San Giuseppe Moscati Hospital | Conditions: Acute Myocardial Infarction | Phase 2, Phase 3 | Status: COMPLETED